Emerging Pharmacotherapies for Diabetic Macular Edema

Figure 2

(a) Fundus photograph, right eye, of a patient with persistent diabetic macular edema following focal/grid photocoagulation. (b) Spectral domain optical coherence tomograph, right eye, demonstrates cystoid macular edema and subretinal fluid. (c) Following additional focal/grid photocoagulation and treatment with intravitreal bevacizumab, 1.25 mg in 0.1 mL, fundus photography demonstrates marked improvement in diabetic macular edema. (d) Follow-up spectral domain optical coherence tomography demonstrates marked improvement in intraretinal and subretinal fluid.